Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
There are posters on this board who generate much fear, uncertainty and doubt (FUD). Their propaganda infers that they are the only ones who know what's going on with this company and that we longs are just a bunch of fools for investing in HALB.
This FUD flies-in-the-face of reality and the positive information that's been released regarding HALB's progress in treating many maladies/diseases that afflict people in the US and around the world - fore-shame on these gamers.
can you tell me about Halberd financials. minus any white paper, which is research by someone, not financial reporting.
No sweat off Hartman's back, he's got another 164 million shares to issue before he's done here. He has nothing to offer but shares...
"Did you ruin BIEI?" "Well, come on over to HALB, I'll lend you all you need to keep things going, just make me a good deal on some shares."-Ryan Goulding
" Cool Beans, be right there. Can I bring my Home Boy? I actually hate him, but I can't come without him."-Hartman talking about Dr. Felder
Now you know, it's all in the financials. Well except the part about Hartman not liking Felder, that comes from first hand experience. To be fair Felder doesn't like Hartman either...
If these people didn't see potential here, they would ask to be paid in cash, not shares.
"Did you ruin BIEI?" "Well, come on over to HALB, I'll lend you all you need to keep things going, just make me a good deal on some shares."
" Cool Beans, be right there. Can I bring my Home Boy? I actually hate him, but I can't come without him."
Insert names as seems appropriate.
Small price to pay to become a successful company
Hartman states a lot of things but they're not specific. This is specific:
7/31/2020 302,721,539 shares outstanding
2/15/2024 635,874,842 shares outstanding
https://www.otcmarkets.com/otcapi/company/financial-report/267088/content
https://www.otcmarkets.com/stock/HALB/security
The fact is Hartman has been saying since he took over this ticker that there would be "no toxic funding" but he diluted the share count by 333,153,303 more than doubling the o/s The majority of those shares were issued to Ryan Goulding not Randy Goulding.
https://www.otcmarkets.com/otcapi/company/financial-report/311582/content
https://www.otcmarkets.com/otcapi/company/financial-report/357034/content
https://www.otcmarkets.com/otcapi/company/financial-report/384904/content
Maybe the US military/government can throw a few measly $Billion in Halberd and fund a company that actually has many viable products that actually help people for a change.
Makes sense to join forces with a company already linked to the government. He knows how to get there.
"The best route is to take it through the military, where testing can be at government expense and certification can be shortened. That is our current plan, and we are just beginning the process to work with the military to that end.
Thanks for your interest in Halberd Corporation and our products.
William A. Hartman
Chairman, President & CEO
Halberd Corporation
Skype: w.a.hartman"
Hartman specifically stated he is absolutely avoiding toxic funding. Randy Goulding is doing 100% of all the legal work involved with the joint venture with Athena GTX and all other legal issues. None of this is done for free. The fact that people are getting shares incentivises everyone to makes this fly. Good luck to all.🤗🙏👍💥💥🧨🧨🔥🔥
Over a million added in just one trade to finish the day. Someone wanted in badly before this went full rocket ship.
We all have different opinions that's what makes markets work. My opinions of HALB are based on what I see in the financials not what Hartman says
Yes but the folks on shark tank aren't CEO of publicly traded companies.
The scheme is different but the end result is the same diluted share owners taking it in the shorts
Why has Ryan Goulding received hundreds of millions of shares issued by HALB since Hartman's taken over?
That's not toxic financing?
Thanks for this explanation...
So when these companies go on shark tank and “give away” part of their company this is dilutive financing too. But in reality the partnership often helps both parties by creating better opportunities and thus more value. This is what Hartman is doing. The difference between this and what Hartman did at BIEI is avoiding toxic financing. These people/companies are not going to turn around and sell these shares back at rock bottom prices and haven’t been. It’s why the price has remained relatively stable over the past few years.
That explains a lot...And your thoughts about the likelihood of Athena helping to secure buy-in from potential suitors in government, Pharma or the military?
Didn't mean to rain on your parade 🤣
That's textbook dilutive funding
The next set of financials will drop in about a month it will show who received the shares and give clarity to the "revenue sharing arrangement"
Halberd is moving forward again with many of their life-saving products - everything looks good at this point.
I suspect those 70 m shares went to Mark Darrah for compensation in exchange for funding this whole project. The timing is right.
Well NOW you've given away the whole Game Plan. lol
I liked that I just gave the thought, and if someone wanted to actually know the truth, they would go do the research. If not.............😜
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=173835672
Last Q - 565,874,842 as of October 31, 2023
OTC now - 635,874,842 as of 02/02/2024
That is what keeps it worth trading IMO. Little pumps = Little profits
Typically anyone that's works with Hartman is given shares of the company as incentive, like Carl Eller. Eller was given 1 million shares to sit on the board and "endorse" HALB. He was also given 1 million shares to endorse BIEI (Hartman's previous venture that he diluted out of business.
Sometimes it's not shares directly to the "research partner" but the JV is funded by shares.
ASU was given $50k/month to do research for HALB and that $50k/month was funded by a well thought scam that ended up adding around 275 million shares being issued.
So no one feels like their "wasting their time and funds" because they are being compensated or at the least incentivized
Bottom line Hartman dilutive financing is all Hartman's knows and when the shares run out he'll move along to the next venture.
It's all in the financials...
Just noticed share count is up 80 million shares since last I checked but Hartman's quick to tout non dilutive funding agreement. What a jack ass.
Can't wait to see the next round of financials.
They are shaking he tree but I'm not selling. :)
" their time--and funds " And where did the funds come from?
Paying close attention to between-the-lines info is always advisable when it concerns stock purchases--particularly those that trade on the OTC. But that still leaves the main question unanswered: Why would major universities like Mississippi State, and ASU, et al, waste their time--and funds--on research projects for a company they hadn't thoroughly investigated beforehand? Perhaps there's a logical explanation but that doesn't make sense to me...
Be careful of how you interpret the PR's and what Hartman says and doesn't say in his interviews.
The next set of financials should reveal why Darrah and Athena are involved.
Darrah made a comment in the last interview that they needed to "clean up" the MSU research, listen carefully.
Hartman's PR group is very good at how they chose words and present content.
Good point about the incremental rise in share price sans significant news...Fingers and toes crossed that it continues into the teens prior to the much anticipated news on contracts and (military?) funding...
And without any news. People are confident.
$0.10 lets go. :)
Based on this stock's history that sounds plausible, but then I'd have to ask how Halberd's paper tiger status escaped notice during the vetting process initiated by Mark Darrah at Athena GTX--not to mention the science administrators at MSU? What would drive either of them to form a partnership with William Hartman if they felt that Halberd's research and, derivatively, their products were fraudulent or nonactionable? Just curious...
It's going to be huge. :)
I wonder if HALB websites been hacked. Acting weird the last few days.
AthenaGTX, Croden Health and other people ARE buying this. Good enough for me.
https://www.otcmarkets.com/stock/HALB/news/Halberd-and-Mississippi-State-University-to-Commence-Stage-II-Advanced-TBI-Nasal-Spray-Testing?id=429883
https://www.otcmarkets.com/stock/HALB/news/Halberds-Top-Executives-Join-Forces-with-Athena-GTX-CEO-Mark-Darrah-Unveiling-2024-Powerful-Partnership-Outlook-on-The-S?id=429566
Tough to listen to, with all this great news one would think there would be more than $500 worth of volume.
Nobody is buying this latest idea from the feeble think tank at HALB
I think I found it . . .
https://finance.yahoo.com/news/halberd-mississippi-state-university-commence-130000945.html
Link please
Income generator and new government access. He knows what he's doing and is making it happen. :)
Judging by this great interview, this association with Mark Darrah and Athena GTX will be a game-changer for Halberd. This will take them to the next level - great things are awaiting those that have been patient.
$HALB Halberd's Top Executives Join Forces with Athena GTX CEO Mark Darrah Unveiling 2024 Powerful Partnership Outlook on "The Street Reports Podcast"
https://www.accesswire.com/831334/halberds-top-executives-join-forces-with-athena-gtx-ceo-mark-darrah-unveiling-2024-powerful-partnership-outlook-on-the-street-reports-podcast
JACKSON CENTER, PA / ACCESSWIRE / February 6, 2024 / Halberd Corporation's (OTC PINK:HALB) and Athena GTX's executives interviewed on "The Street Reports," discuss the relationship between Halberd and Athena and why that relationship is going to advance Halberd's breakthrough technologies toward government contracts.
Listen here: https://thestreetreports.com/halb-ceo-william-hartman-cto-dr-mitchell-felder-and-ceo-of-athena-gtx-mark-darrah-discuss-company-partnership-and-optimistic-2024-on-the-street-reports-podcast-listen-now/
To get the latest on Halberd's exciting developments, subscribe by submitting this form.
(https://halberdcorporation.com/contact-us/).
(responsible mod: Bill Moynihan/EHRjunkie)
Halberd Corp. (OTC PINK:HALB), is a publicly traded company on the OTC Market, and is in full compliance with OTC Market reporting requirements.
Halberd holds the exclusive rights to 4 granted U.S. Patents, no. 9,216,386 no. 8,758,287 and no. 11,186,629, no. 8,865,733
Halberd Corporation is a biotechnology company and with its partners (Dr. Qiang Shawn Chen and his team at Arizona State University; Dr. William Sturrus and his team at Youngstown State University; Dr. Richard Carr and his team at Mississippi State University), is developing an extra-corporeal (out of the body) treatment against PTSD, CTE, Alzheimer's Disease and other virusses and diseases. With the use of antibodies the disease antigens is targeted. Using radiofrequency / laser technology the "antibody-metallic moiety-antigens complex" is destroyed/eradicated. All based on 4 granted patents and 22 pending provisional/non-provisional (some PCT) patent applications.
2024: In close cooperation with partner (revenue sharing agreement in place) AthenaGTX, Halberd Corp is working on contracts from the military, to develop treatments to tackle Traumatic Brain Injury/TBI (patent pending nasal spray) and Post Traumatic Stress Syndrome/PTSD (patented Low-Dose-Naltrexone product).
JACKSON CENTER, PA / ACCESSWIRE / March 14, 2023 / Halberd Corporation (OTC PINK:HALB) is scheduled to meet with Center of Disease Control (CDC) representatives to discuss Halberd's incredible success in eradicating multiple strains of antibiotic resistant (AR) E. coli bacteria and Candida auris samples previously provided by the CDC.
JACKSON CENTER, PA / ACCESSWIRE / September 6, 2023 / Halberd Corporation's (OTC PINK:HALB) research at Mississippi State University (MSU) has shown significant reduction in two key markers of traumatic brain injury (TBI) in early testing of Halberd's patent-pending nasal spray to mitigate the effects of TBI. Anecdotal data in preliminary testing reveals a 20% reduction in Neuron Specific Enolase and a 50% reduction in the levels of Glial Fibrillary Acid Protein compared to the control group.
JACKSON CENTER, PA / ACCESSWIRE / September 20, 2023 / Halberd Corporation (OTC PINK:HALB) and Athena GTX, Inc, of Johnston, Iowa commenced collaboration on critical development of submissions for government contracts seeking proposals for the detection and treatment of traumatic brain injury (TBI). The initial focus will be on accelerating and fine-tuning Halberd's proprietary nasal spray for suppressing the effects of traumatic brain injury (TBI).
JACKSON CENTER, PA / ACCESSWIRE / December 13, 2023 / Halberd Corporation (OTC PINK:HALB) and CrodenHealth.com of Canada agree to produce, market, sell and distribute Halberd's patented low dose naltrexone combo product(s) worldwide. The agreement also allows CrodenHealth.com right of first refusal regarding similar rights to future products in Halberd's development pipeline.
JACKSON CENTER, PA / ACCESSWIRE / January 10, 2024 / Halberd Corporation (OTC-PINK:HALB) is thrilled to declare the formalization of a profitable revenue-sharing accord with Athena GTX, Inc., of Johnston, Iowa, (www.athenagtx.com). Athena GTX is a private enterprise specializing in providing medical care solutions tailored for first responders in both civilian and government sectors.
Halberd's / Athena's treatment for PTSD is called WatchDawg
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |